Professor Omur Gokmen Sevindik
5
reviews
01/05/2025
01/05/2025
01/05/2023
01/05/2025
01/05/2022
Professor Omur Gokmen Sevindik — a hematologist focused on the treatment of blood disorders, especially multiple myeloma and other plasma cell diseases. After graduating from the English-language program at Hacettepe Medical School in 2005, he completed his residency in internal medicine and then a subspecialty fellowship in hematology at Dokuz Eylül University (Izmir).
In 2014 he completed a clinical fellowship at the Mayo Clinic (USA) under the world’s leading specialists in multiple myeloma, Waldenström’s macroglobulinemia, and amyloidosis — and this field has since become his key focus.
Today Professor Sevindik heads the Hematology Department at Istanbul Florence Nightingale Hospital and at the same time serves as Professor at the Department of Internal Medicine / Hematology of Demiroglu Bilim University.
In his research work he has been principal or co-investigator in more than 30 phase 1–3 clinical trials, has authored more than 50 peer-reviewed publications and over 200 conference presentations. He is a member of the American Society of Hematology (ASH), the European Hematology Association (EHA), ASCO, and the Turkish Society of Hematology (TSH), where he previously chaired the scientific subcommittee on multiple myeloma.
Achievements and awards
About Doctor Omur Gokmen Sevindik
Hematology, hemato-oncology, and bone marrow transplantation.
Main areas of specialization:
- treatment of leukemias (acute and chronic forms);
- treatment of lymphomas;
- treatment of multiple myeloma;
- bone marrow and stem cell transplantation;
- autologous and allogeneic bone marrow transplantation;
- treatment of myelodysplastic syndrome;
- treatment of aplastic anemia and other blood disorders;
- targeted therapy and modern drug treatment of hemato-oncologic diseases;
- follow-up of patients after bone marrow transplantation;
- treatment of post-transplant complications;
- diagnosis and treatment of blood coagulation disorders;
- participation in international clinical trials in hematology.
- 2005 — Faculty of Medicine, Hacettepe University, English-language program, Doctor of Medicine degree
- 2005–2010 — residency in internal medicine, Dokuz Eylül University, Izmir
- 2011–2015 — fellowship in hematology, Dokuz Eylül University
- 2014 — clinical fellowship in the treatment of plasma cell diseases, Mayo Clinic (USA)
- 2017 — awarded the title of Associate Professor
- 2022 — awarded the title of Professor
- 2010–2015 — Dokuz Eylül University, Department of Internal Medicine and Hematology
- 2015–2022/2023 — Faculty of Medicine, Medipol University, Department of Hematology, Medipol Mega University Hospital
- Currently — Florence Nightingale Hospital in Istanbul, Head of the Hematology Department
- Professor at the Faculty of Medicine, Demiroglu Bilim University (current academic activity)
- Author and co-author of more than 50 publications in international peer-reviewed medical journals.
- ResearchGate profile: more than 100 scientific publications and hundreds of citations in the scientific literature.
- Principal investigator and co-investigator in more than 30 international phase I–III clinical trials.
- Participated in major multicenter studies of the Turkish Society of Hematology on leukemias, lymphomas, and multiple myeloma.
- Turkish Hematology Association (TSH) — member of the association, former chair of the scientific subcommittee on multiple myeloma
- European Hematology Association (EHA) — member since 2012
- American Society of Hematology (ASH) — member since 2015
- American Society of Clinical Oncology (ASCO) — member since 2015
- Society of Hematologic Oncology (SOHO) — member since 2014
Istanbul Florence Nightingale Hospital — the flagship of the Group Florence Nightingale Hospitals network, one of the oldest private medical groups in Turkey (founded in 1989 under the auspices of the Turkish Society of Cardiology).
The hospital is JACIE-accredited and works closely with Demiroglu Bilim University.
For patients with blood disorders, the Hematology Center and Bone Marrow Transplantation Center is of key importance, with its own transplantation program from related, unrelated, and haploidentical donors.
The Hematology Department, under the leadership of Professor Sevindik, focuses on the comprehensive treatment of multiple myeloma, amyloidosis, and other plasma cell diseases; the treatment of acute and chronic leukemias, lymphomas, and myelodysplastic syndromes; and participation in international phase 1–3 clinical trials — giving patients access to modern targeted and immunotherapy drugs.
Florence Nightingale is one of the 8 project partners of the Turkish Society of Hematology.
An international department serves foreign patients.
